Association of study design features and treatment effects in trials of chronic medical conditions: a meta-epidemiological study

Zhen Wang(Mayo Clinic), M. Hassan Murad(Mayo Clinic), Fares Alahdab(University of Missouri), Tabinda Jawaid(Mayo Clinic), Mohammed Firwana(Mayo Clinic in Arizona), Magdoleen H. Farah(Mayo Clinic in Arizona), Tarek Nayfeh(Mayo Clinic), Mohamed O. Seisa(Mayo Clinic), Rami Rajjoub(Mayo Clinic), Samer Saadi(Mayo Clinic in Arizona)
BMJ evidence-based medicine
July 1, 2021
10.1136/bmjebm-2021-111667
Cited by 9

Related Papers

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2018|14k
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2017|13.5k
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2018|8.7k
Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|5.7k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k